A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities

Last updated: August 5, 2025
Sponsor: Regor Pharmaceuticals Inc.
Overall Status: Completed

Phase

2

Condition

Obesity

Diabetes Prevention

Hypertriglyceridemia

Treatment

Placebo

RGT001-075

Clinical Study ID

NCT06277934
RGT001-075-203
  • Ages 18-75
  • All Genders

Study Summary

The main purpose of this study was to evaluate the safety and tolerability of RGT001-075 in healthy participants with obesity

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18 and ≤ 75 years

  • Have a BMI ≥27 kg/m² and ≤ 45 kg/m²

  • Have had a stable body weight for the 3 months prior to randomization

Exclusion

Exclusion Criteria:

  • Have obesity induced by other endocrinologic disorders or diagnosed monogenetic orsyndromic forms of obesity

  • Have a prior or planned surgical treatment for obesity

  • Have or plan to have endoscopic and/or device-based therapy for obesity

  • Have any prior diagnosis of diabetes

  • Have an electrocardiogram (ECG) with abnormalities

  • Have a history of Major Depressive Disorder (MDD) or other severe psychiatricdisorders within the last 2 years

  • Have a history of suicide attempt.

Study Design

Total Participants: 73
Treatment Group(s): 2
Primary Treatment: Placebo
Phase: 2
Study Start date:
March 08, 2024
Estimated Completion Date:
August 13, 2024

Connect with a study center

  • Velocity Clinical Research

    Los Angeles, California 90057
    United States

    Site Not Available

  • Velocity Clinical Research

    Valparaiso, Indiana 46383
    United States

    Site Not Available

  • Velocity Clinical Research

    Omaha, Nebraska 68134
    United States

    Site Not Available

  • Velocity Clinical Research

    Vestal, New York 13850
    United States

    Site Not Available

  • Velocity Clinical Research

    Durham, North Carolina 27701
    United States

    Site Not Available

  • Velocity Clinical Research

    Cleveland, Ohio 44122
    United States

    Site Not Available

  • Velocity Clinical Research

    Medford, Oregon 97504
    United States

    Site Not Available

  • Velocity Clinical Research

    East Greenwich, Rhode Island 02818
    United States

    Site Not Available

  • Velocity Clinical Research

    Dallas, Texas 75230
    United States

    Site Not Available

  • Velocity Clinical Research

    West Jordan, Utah 84088
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.